HBC — Hofseth Biocare ASA Cashflow Statement
0.000.00%
- NOK837.57m
- NOK977.32m
- NOK194.87m
Annual cashflow statement for Hofseth Biocare ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -89.2 | -102 | -126 | -137 | -107 |
Depreciation | |||||
Non-Cash Items | 8.06 | 9.45 | 9.36 | 9.75 | -11.5 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 22.6 | 4.25 | 26 | 52.1 | 84.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -31.1 | -61.6 | -61.8 | -45.2 | 2.76 |
Capital Expenditures | -20.1 | -54.5 | -37.8 | -17.8 | -14.1 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.449 | -5.6 | -0.188 | 0 | -0.93 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -19.6 | -60.1 | -37.9 | -17.8 | -15 |
Financing Cash Flow Items | -11.9 | -14.1 | -9.39 | -10.3 | -10.5 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 96.6 | 200 | -23.2 | 45.5 | 3.69 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 45.9 | 78.3 | -123 | -17.5 | -8.54 |